Similar articles

• Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia.

  Ossenkoppele GJ, Janssen JJ, van de Loosdrecht AA. Ossenkoppele GJ, et al. Haematologica. 2016 Jan;101(1):20-5. doi: 10.3324/haematol.2015.139105. Haematologica. 2016. PMID: 26721801 Free PMC article. Review.
• Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?

  Caira M, Girmenia C, Fadda RM, Mitra ME, Picardi M, Van Lint MT, Nosari A, Candoni A, Bonini A, Mattei D, de Waure C, Fianchi L, Valentini CG, Aversa F, Leone G, Pagano L. Caira M, et al. Eur J Haematol. 2008 Sep;81(3):242-3. doi: 10.1111/j.1600-0609.2008.01096.x. Epub 2008 May 11. Eur J Haematol. 2008. PMID: 18485113 No abstract available.
• Clinical experience with posaconazole prophylaxis--a retrospective analysis in a haematological unit.

  Hahn J, Stifel F, Reichle A, Holler E, Andreesen R. Hahn J, et al. Mycoses. 2011 Jan;54 Suppl 1:12-6. doi: 10.1111/j.1439-0507.2010.01980.x. Mycoses. 2011. PMID: 21126267
• High Infection-Related Mortality in Pediatric Acute Myeloid Leukemia without Preventive Antibiotics and Antifungals: Retrospective Cohort Study of a Single Center from a Middle-Income Country.

  Zengin E, Sarper N, Aylan Gelen S, Demirsoy U, Karadoğan M, Çakı Kılıç S, Öncel S, Arısoy ES, Dündar D. Zengin E, et al. Turk J Haematol. 2017 Dec 1;34(4):340-344. doi: 10.4274/tjh.2017.0052. Epub 2017 Mar 29. Turk J Haematol. 2017. PMID: 28351828 Free PMC article.
• Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach.

  Lodewyck T, Cornelissen JJ. Lodewyck T, et al. Blood Rev. 2008 Nov;22(6):293-302. doi: 10.1016/j.blre.2008.03.008. Epub 2008 May 1. Blood Rev. 2008. PMID: 18455284 Review.